A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Healthy Participants
Interventions: DRUG: AZD5462|DRUG: Midazolam|DRUG: Rosuvastatin|DRUG: Digoxin
Sponsor: AstraZeneca
Collaborators: Parexel